Factors of medicine accessibility
People often think of breakthroughs in medicine happening in the lab, at the molecular level, often leading to patents for new name brand drugs. Though it comes at an expense, this level of R&D is incredibly valuable and has helped millions of people live better, longer lives. But there are also many ways innovation can define or redefine the standard of care beyond the molecule, from smarter formulations, new delivery and administration approaches, and dosing simplicity that make treatments easier to start, simpler to stay on, and more in tune with the realities of patients’ daily lives.
A major barrier to access lies not in the absence of treatment options, but in the complexity surrounding them. Approximately 50% of prescriptions are taken incorrectly, particularly with regard to timing, dosage, frequency, and duration. For many patients, managing a chronic condition requires navigating multi-step dosing, difficult administration, uncomfortable side effects, and frequent appointments. These friction points can undermine overall adherence to treatment plans and compromise outcomes.
Furthermore, many patients face health equity barriers that limit their access to essential medicines and necessary treatment. Innovations that allow for home administration and reduced reliance on in-clinic monitoring, or products designed for longer shelf life can make treatment significantly more accessible. When innovative home-administration options are given, 70% to 100% of patients report higher satisfaction and greater willingness to continue home-based treatment.
Total number of “Breakthrough therapies” approved by the U.S. FDA in all of 2024
Source: U.S. FDA
Proportion of patients who report higher satisfaction with home-based treatment
Patients taking an innovative polypill treatment that lowers the number of doses required increase medication adherence 21.6% over standard treatment
Source: National Library of Medicine
Innovation across the medicine ecosystem focused on real patient needs—from novel molecules to easier to use formats and simpler dosing can collectively help people gain access to outcomes and lifestyles not previously possible.
The discovery and development of novel medicines, including first-in-class or differentiated therapies, that address unmet needs by treating new diseases or existing diseases in fundamentally new ways
Innovations in how medicines are formulated, delivered, or administered that improve ease of use for patients, efficiency for providers, or preparation by pharmacists including approaches that reduce burden, enable new care settings, or improve adherence and outcomes
New ways of organizing, partnering, and operating across manufacturers, governments, healthcare organizations, states, and other stakeholders to develop, distribute, or deliver medicines, expanding reach, accelerating access, or enabling care in settings not previously possible
Innovation in healthcare extends beyond the molecule itself. How a therapy is formulated, administered, and dosed can significantly shape a patient’s ability to start and stay on treatment. By rethinking delivery methods, simplifying dosing, and designing formulations that more seamlessly fit real-world use cases, innovation can expand access to care.
Amneal is committed to innovation that improves how patients experience and access care. We focus on developing differentiated medicines and delivery technologies that simplify treatment, reduce complexity, and support better adherence over time.
By advancing formulations, dosing approaches, and delivery mechanisms, Amneal works to turn scientific progress into patient-centered solutions that meet real needs.
The information presented in this Accessibility Index is compiled from publicly available sources believed to be reliable at the time of publication. However, Amneal makes no representations or warranties, express or implied, regarding the accuracy, completeness, or timeliness of the data provided. The content is for informational purposes only and does not constitute professional advice or endorsement.
The views and opinions expressed in this index do not necessarily reflect those of Amneal, its affiliates, or its employees. Amneal disclaims any liability for any decisions made or actions taken based on the information contained herein.
This index is intended to support awareness and understanding of medicine accessibility and is not a substitute for professional consultation or regulatory guidance. Users are encouraged to verify information independently and consult appropriate experts before making decisions.
By using this site, you acknowledge and agree to these terms.